Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,243.00
Bid: 1,244.80
Ask: 1,245.80
Change: 18.80 (1.54%)
Spread: 1.00 (0.08%)
Open: 1,212.40
High: 1,247.00
Low: 1,210.80
Yest. Close: 1,224.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

China fines GSK $489 mln, jails executives -Xinhua

BEIJING, Sept 19 (Reuters) - China has fined British pharmaceuticals giant GlaxoSmithKline Plc 3 billion yuan ($488.8 million) for paying out bribes in what is a record penalty for China, state news agency Xinhua said on Friday. Mark Reilly, the former head of GSK in China, and other GSK ex

19 Sep 14 08:25

Glaxo Fined GBP297 Million As China Arm Is Found Guilty Of Bribery

19 Sep 14 08:21

UPDATE 1-Iraq loses U.S. appeal in U.N. oil-for-food lawsuit

(Adds details from decision, dissent, comments) By Jonathan Stempel NEW YORK, Sept 18 (Reuters) - A U.S. federal appeals court on Thursday rejected Iraq's effort to sue dozens of companies for allegedly conspiring with the Saddam Hussein regime to subvert the United Nations' oil-for-f

18 Sep 14 16:53

BUZZ-Weaker GBP offers a silver lining for UK MNCs

** When the dust settles following tonight's Scottish referendum, any sustained sterling weakness that arises will offer some UK bluechips something to cheer about. ** Impact of a stronger pound has been a key theme for last 2 quarterly earnings seasons and has hit revisions and EPS forecas

18 Sep 14 15:53

Iraq loses U.S. appeal over U.N. oil-for-food program suit

By Jonathan Stempel NEW YORK, Sept 18 (Reuters) - A divided U.S. federal appeals court on Thursday rejected Iraq's effort to sue dozens of companies for allegedly conspiring with the Saddam Hussein regime to frustrate the United Nations' oil-for-food program. By a 2-1 vote, the 2nd U.

18 Sep 14 15:36

Boehringer to pay up to $600 mln for CureVac cancer vaccine

Sept 18 (Reuters) - Boehringer Ingelheim is betting on a cancer vaccine to fight lung tumours after signing a deal worth up to $600 million with U.S.-based CureVac, despite recent disappointments with cancer vaccines from rival firms. The unlisted German drugmaker said on Thursday it was in

18 Sep 14 12:11

GSK melanoma pill backed by UK cost watchdog with price cut

LONDON, Sept 18 (Reuters) - Britain's healthcare cost agency NICE has recommended a third new drug for melanoma, this time from GlaxoSmithKline, after the drugmaker offered to supply it at a discount to the state-run National Health Service. GSK currently markets Tafinlar but the product wi

17 Sep 14 23:01

UPDATE 1-First UK volunteer gets experimental GSK Ebola shot in trial

(Adds details, quotes from lead investigator, background) By Kate Kelland LONDON, Sept 17 (Reuters) - The first volunteer in a fast-tracked British safety trial of an experimental Ebola vaccine made by GlaxoSmithKline received the injection on Wednesday, trial organisers said. T

17 Sep 14 16:00

First UK volunteer gets experimental GSK Ebola shot in trial

By Kate Kelland LONDON, Sept 17 (Reuters) - The first volunteer in a fast-tracked British safety trial of an experimental Ebola vaccine made by GlaxoSmithKline received the injection on Wednesday, trial organisers said. The candidate Ebola vaccine, which GSK co-developed with the Unit

17 Sep 14 12:18

Trial for vaccine against Ebola set to start in Oxford

Sixty healthy Britons will take part in a trial for a vaccine against Ebola at Oxford. The volunteers will be injected with the virus by experts at the University of Oxford in a fast-tracked process which aims to stop the spread of the fatal disease. The vaccine was developed by the US National Ins

17 Sep 14 10:10

RPT-Ebola vaccine trial finds 'no red flags': U.S. Senate testimony

(Repeats to widen distribution, no change to headline or text) NEW YORK, Sept 16 (Reuters) - A key safety trial of an experimental Ebola vaccine manufactured by GlaxoSmithKline has injected 10 healthy volunteers since Sept. 2, Dr. Anthony Fauci of the National Institute of Allergy and Infe

16 Sep 14 20:00

Ebola vaccine trial finds 'no red flags': U.S. Senate testimony

NEW YORK, Sept 16 (Reuters) - A key safety trial of an experimental Ebola vaccine manufactured by GlaxoSmithKline has injected 10 healthy volunteers since Sept. 2, Dr. Anthony Fauci of the National Institute of Allergy and Infectious Diseases told a U.S. Senate panel on Tuesday, and so far "no r

16 Sep 14 19:53

UK BROKER RATINGS: Shore Capital Upgrades Carnival To Buy

15 Sep 14 08:31

First person in UK trial to get experimental Ebola shot next week

By Kate Kelland LONDON, Sept 12 (Reuters) - The first human volunteer in a fast-tracked British safety trial of an experimental vaccine to fight Ebola is to be injected with the shot next week, organisers of the trial said on Friday. The candidate Ebola vaccine is being co-developed b

12 Sep 14 15:13

INSIGHT-As Big Tobacco takes up e-cigarettes, investors look ahead

* Sector not as attractive for private funds as it once was * NJOY piques interest of Big Tobacco and Pharma-sources * Gamucci close to fund raising, new product launch-CEO * BAT says nicotine inhaler licensed as medical product By Martinne Geller and Jilian Mincer L

12 Sep 14 10:17

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.